As a result, a new ferroptosis inhibition axis with GTP cyclohydrolase-1 (GCH1) as the core was finally determined, which was found to be mainly regulated by the GCH1/BH4/DHFR pathway, which also protected cells from ferroptosis in a GPX4-independent manner (49, 50) ( Figure 1D )
4 In a rigorous trial involving over 17,600 participants, Wegovy significantly reduced the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke
Early detection can prevent further complications
Over 100 million Americans watched Hims & Hers (HIMS) controversial Super Bowl ad taking on the weight-loss drug industry this Sunday during the Super Bowl.
ORFORGLIPRON Eli Lilly (the manufacturer of Mounjaro), has its own oral GLP-1 drug, orforglipron, that according to Eli Lilly, shows people without type two diabetes seeing weight reduction between 14% and 15% over the course of 36 weeks, whereas those with type two diabetes saw weight loss of about 9.6% over the same time frame
Primarily used for type 2 diabetes, shares similarities with Wegovys mechanism of action
